NDC Product
Human Otc DrugDna Insulin Drops 2019 NDC 63083-2019
- Generic Name
- Dna Insulin Drops
- Dosage Form
- Liquid
- Route
- Oral
- Marketing
- UNAPPROVED HOMEOPATHIC
Active Listing
This profile provides standardized clinical and technical data for Insulin Glulisine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7XIY785AZD.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 207748-29-6 and the RxNorm Concept ID (RxCUI) 400008. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
This section provides a complete list of nomenclature and identifier mappings for Insulin Glulisine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: